{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:57:11Z","timestamp":1785769031077,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01375"],"award-info":[{"award-number":["PI17\/01375"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01375"],"award-info":[{"award-number":["PI17\/01375"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02831-4","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:53:46Z","timestamp":1752137626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Remnant\u2013to\u2013LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Eva","family":"Soler-Espejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Rivera-Caravaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Ramos-Bratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"L\u00f3pez-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2831_CR1","doi-asserted-by":"crossref","unstructured":"Linz D, Gawalko M, Betz K, Hendriks JM, Lip GY, Vinter N et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg Health\u2013Europe. 2024;37.","DOI":"10.1016\/j.lanepe.2023.100786"},{"key":"2831_CR2","doi-asserted-by":"crossref","unstructured":"Chao T-F, Potpara TS, Lip GY. Atrial fibrillation: stroke prevention. Lancet Reg Health\u2013Europe. 2024;37.","DOI":"10.1016\/j.lanepe.2023.100797"},{"issue":"4","key":"2831_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","volume":"23","author":"DJ Seiffge","year":"2024","unstructured":"Seiffge DJ, Cancelloni V, R\u00e4ber L, Paciaroni M, Metzner A, Kirchhof P, et al. Secondary stroke prevention in people with atrial fibrillation: treatments and trials. Lancet Neurol. 2024;23(4):404\u201317.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2831_CR4","first-page":"187","volume":"8","author":"P Burdett","year":"2022","unstructured":"Burdett P, Lip GY. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart Journal-Quality Care Clin Outcomes. 2022;8(2):187\u201394.","journal-title":"Eur Heart Journal-Quality Care Clin Outcomes"},{"issue":"2","key":"2831_CR5","first-page":"221","volume":"4","author":"M Leung","year":"2018","unstructured":"Leung M, van Rosendael PJ, Abou R, Ajmone Marsan N, Leung DY, Delgado V, et al. The impact of atrial fibrillation clinical subtype on mortality. JACC: Clin Electrophysiol. 2018;4(2):221\u20137.","journal-title":"JACC: Clin Electrophysiol"},{"issue":"3","key":"2831_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/cvr\/cvab017","volume":"118","author":"WY Ding","year":"2022","unstructured":"Ding WY, Protty MB, Davies IG, Lip GY. Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovascular Res. 2022;118(3):716\u201331.","journal-title":"Cardiovascular Res"},{"issue":"10226","key":"2831_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795\u2013808.","journal-title":"Lancet"},{"issue":"8","key":"2831_CR8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.amjcard.2016.12.031","volume":"119","author":"Z Qi","year":"2017","unstructured":"Qi Z, Chen H, Wen Z, Yuan F, Ni H, Gao W, et al. Relation of low-density lipoprotein cholesterol to ischemic stroke in patients with nonvalvular atrial fibrillation. Am J Cardiol. 2017;119(8):1224\u20138.","journal-title":"Am J Cardiol"},{"key":"2831_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11239-020-02110-x","volume":"50","author":"W Liu","year":"2020","unstructured":"Liu W, Xiong N, Xie K, Wu B, Qi Z, Zhou P, et al. A stricter control of low-density lipoprotein is necessary for thrombosis reduction in lower thrombosis risk patients with atrial fibrillation: a multicenter retrospective cohort study. J Thromb Thrombolysis. 2020;50:849\u201357.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"2831_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.amjmed.2020.08.035","volume":"134","author":"A Omelchenko","year":"2021","unstructured":"Omelchenko A, Hornik-Lurie T, Gabay H, Minha S, Assali A, Pereg D. LDL cholesterol and ischemic stroke in patients with nonvalvular atrial fibrillation. Am J Med. 2021;134(4):507\u201313.","journal-title":"Am J Med"},{"issue":"4","key":"2831_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MOL.0000000000000429","volume":"28","author":"A Varbo","year":"2017","unstructured":"Varbo A, Nordestgaard BG. Remnant lipoproteins. Curr Opin Lipidol. 2017;28(4):300\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"2831_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12933-023-01927-z","volume":"22","author":"B Guan","year":"2023","unstructured":"Guan B, Wang A, Xu H. Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a Mendelian randomization analysis. Cardiovasc Diabetol. 2023;22(1):207.","journal-title":"Cardiovasc Diabetol"},{"issue":"20","key":"2831_CR13","doi-asserted-by":"publisher","first-page":"e035764","DOI":"10.1161\/JAHA.124.035764","volume":"13","author":"C Cui","year":"2024","unstructured":"Cui C, Li P, Qi Y, Song J, Han T, Shang X, et al. Intraindividual discordance between remnant cholesterol and Low-Density lipoprotein cholesterol associated with incident stroke: results from 2 National cohorts. J Am Heart Association. 2024;13(20):e035764.","journal-title":"J Am Heart Association"},{"issue":"3","key":"2831_CR14","doi-asserted-by":"publisher","first-page":"e14371","DOI":"10.1111\/eci.14371","volume":"55","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen Y, Olier I, Ortega-Martorell S, Huang B, Ishiguchi H, et al. Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: A report from the GLORIA-AF registry phase II\/III. Eur J Clin Invest. 2025;55(3):e14371.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2831_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"key":"2831_CR16","doi-asserted-by":"crossref","unstructured":"Teppo K, Lip GYH, Airaksinen KEJ, Halminen O, Haukka J, Putaala J, et al. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a Temporal trends analysis from the retrospective Finnish anticoagulation in atrial fibrillation (FinACAF) cohort. The Lancet Regional Health\u2013Europe; 2024. p. 43.","DOI":"10.1016\/j.lanepe.2024.100967"},{"issue":"5","key":"2831_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"key":"2831_CR18","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA et al. \/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019;73(24):e285-e350.","DOI":"10.1016\/j.jacc.2018.11.003"},{"issue":"34","key":"2831_CR19","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FL Visseren","year":"2021","unstructured":"Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice: developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European society of cardiology and 12 medical societies with the special contribution of the European association of preventive cardiology (EAPC). Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"issue":"16","key":"2831_CR20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","volume":"44","author":"BN Wadstr\u00f6m","year":"2023","unstructured":"Wadstr\u00f6m BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023;44(16):1432\u201345.","journal-title":"Eur Heart J"},{"issue":"25","key":"2831_CR21","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points\u2014a joint consensus statement from the European atherosclerosis society and European federation of clinical chemistry and laboratory medicine. Eur Heart J. 2016;37(25):1944\u201358.","journal-title":"Eur Heart J"},{"key":"2831_CR22","unstructured":"Hu D-Y. New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China\u2606. Chinese Medical Journals Publishing House Co., Ltd. 42 Dongsi Xidajie\u2026 pp. 73\u2013\u20094."},{"issue":"23","key":"2831_CR23","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","volume":"76","author":"O Casta\u00f1er","year":"2020","unstructured":"Casta\u00f1er O, Pint\u00f3 X, Subirana I, Amor AJ, Ros E, Hern\u00e1ez \u00c1, et al. Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76(23):2712\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2831_CR24","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.2337\/dc21-2511","volume":"45","author":"L Fu","year":"2022","unstructured":"Fu L, Tai S, Sun J, Zhang N, Zhou Y, Xing Z, et al. Remnant cholesterol and its visit-to-visit variability predict cardiovascular outcomes in patients with type 2 diabetes: findings from the ACCORD cohort. Diabetes Care. 2022;45(9):2136\u201343.","journal-title":"Diabetes Care"},{"issue":"1","key":"2831_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-024-02537-z","volume":"24","author":"Z Li","year":"2025","unstructured":"Li Z, Yu C, Zhang H, Chen R, Zhao Y, Zheng Z. Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study. Cardiovasc Diabetol. 2025;24(1):8.","journal-title":"Cardiovasc Diabetol"},{"key":"2831_CR26","doi-asserted-by":"crossref","unstructured":"Pirillo A, Catapano AL. Remnant cholesterol: a reliable prognostic marker? Oxford University Press UK; 2024. pp. 1203\u20134.","DOI":"10.1093\/eurjpc\/zwad107"},{"issue":"5","key":"2831_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","volume":"27","author":"J Bor\u00e9n","year":"2016","unstructured":"Bor\u00e9n J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473\u201383.","journal-title":"Curr Opin Lipidol"},{"issue":"47","key":"2831_CR28","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European atherosclerosis society. Eur Heart J. 2021;42(47):4791\u2013806.","journal-title":"Eur Heart J"},{"key":"2831_CR29","doi-asserted-by":"publisher","first-page":"903390","DOI":"10.3389\/fcvm.2022.903390","volume":"9","author":"B Liu","year":"2022","unstructured":"Liu B, Fan F, Zheng B, Yang Y, Jia J, Sun P, et al. Association of remnant cholesterol and lipid parameters with new-onset carotid plaque in Chinese population. Front Cardiovasc Med. 2022;9:903390.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2831_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","volume":"40","author":"PB Sandesara","year":"2019","unstructured":"Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40(2):537\u201357.","journal-title":"Endocr Rev"},{"issue":"11","key":"2831_CR31","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/eurjpc\/zwad036","volume":"30","author":"SJ Lee","year":"2023","unstructured":"Lee SJ, Kim S-E, Go T-H, Kang DR, Jeon H-S, Kim Y-I, et al. Remnant cholesterol, low-density lipoprotein cholesterol, and incident cardiovascular disease among koreans: a National population-based study. Eur J Prev Cardiol. 2023;30(11):1142\u201350.","journal-title":"Eur J Prev Cardiol"},{"issue":"42","key":"2831_CR32","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and apob: a primary prevention study. Eur Heart J. 2021;42(42):4324\u201332.","journal-title":"Eur Heart J"},{"issue":"6","key":"2831_CR33","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1161\/STROKEAHA.121.037756","volume":"53","author":"W Li","year":"2022","unstructured":"Li W, Huang Z, Fang W, Wang X, Cai Z, Chen G, et al. Remnant cholesterol variability and incident ischemic stroke in the general population. Stroke. 2022;53(6):1934\u201341.","journal-title":"Stroke"},{"issue":"17","key":"2831_CR34","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","volume":"75","author":"EK Duran","year":"2020","unstructured":"Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. J Am Coll Cardiol. 2020;75(17):2122\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2831_CR35","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1093\/eurjpc\/zwaa152","volume":"29","author":"A Hussain","year":"2022","unstructured":"Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, et al. Triglyceride-rich lipoproteins, Apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: atherosclerosis risk in communities (ARIC) study. Eur J Prev Cardiol. 2022;29(2):e53\u201364.","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"2831_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74(8):1107\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2831_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","volume":"58","author":"B Verg\u00e8s","year":"2015","unstructured":"Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886\u201399.","journal-title":"Diabetologia"},{"key":"2831_CR38","doi-asserted-by":"crossref","unstructured":"Burnett JR, Hooper AJ, Hegele RA. Remnant cholesterol and atherosclerotic cardiovascular disease risk. American College of Cardiology Foundation Washington DC; 2020. pp. 2736\u20139.","DOI":"10.1016\/j.jacc.2020.10.029"},{"key":"2831_CR39","doi-asserted-by":"crossref","unstructured":"Han M, Huang K, Shen C, Hu H, Liu F, Li J et al. Discordant high remnant cholesterol with LDL-C increases the risk of stroke: A Chinese prospective cohort study. Stroke. 2024.","DOI":"10.1161\/STROKEAHA.124.046811"},{"issue":"8","key":"2831_CR40","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.hrthm.2024.05.044","volume":"21","author":"Z-T Chen","year":"2024","unstructured":"Chen Z-T, Guo D-C, Gao J-W, Gao Q-Y, Zhang Y-P, He W-B, et al. Low remnant cholesterol and the subsequent risk of new-onset atrial fibrillation: A prospective cohort study. Heart Rhythm. 2024;21(8):1258\u201366.","journal-title":"Heart Rhythm"},{"key":"2831_CR41","doi-asserted-by":"crossref","unstructured":"Ouyang X, Tang X, Peng L, Wu H, Wang J, Huang Z et al. Remnant cholesterol and new-onset atrial fibrillation: the atherosclerosis risk in communities study. Heart Rhythm. 2024.","DOI":"10.1016\/j.hrthm.2024.10.030"},{"issue":"10","key":"2831_CR42","doi-asserted-by":"publisher","first-page":"e033840","DOI":"10.1161\/JAHA.123.033840","volume":"13","author":"L Li","year":"2024","unstructured":"Li L, Wang C, Ye Z, Van Spall HG, Zhang J, Lip GY, et al. Association between remnant cholesterol and risk of incident atrial fibrillation: Population-Based evidence from a Large\u2010Scale prospective cohort study. J Am Heart Association. 2024;13(10):e033840.","journal-title":"J Am Heart Association"},{"key":"2831_CR43","doi-asserted-by":"crossref","unstructured":"Soler-Espejo E, Ramos-Bratos MP, Gonz\u00e1lez-Lozano E, Lip GY, Mar\u00edn F, Rivera-Caravaca JM et al. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation. Eur J Prev Cardiol. 2025:zwaf287.","DOI":"10.1093\/eurjpc\/zwaf287"},{"key":"2831_CR44","doi-asserted-by":"crossref","unstructured":"Yao H, Zhang A, Li D, Wu Y, Wang C-Z, Wan J-Y et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ. 2024;384.","DOI":"10.1136\/bmj-2023-076410"},{"issue":"9","key":"2831_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1055\/a-2278-8769","volume":"124","author":"DS Kang","year":"2024","unstructured":"Kang DS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, et al. Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study. Thromb Haemost. 2024;124(9):883\u201392.","journal-title":"Thromb Haemost"},{"issue":"1","key":"2831_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12944-025-02552-3","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Chen Y-Y, Chien K-L, Lin Y-J, Chen F-Y, Hsieh Y-C, et al. Long-term trajectories of Apolipoprotein A1 and major adverse cardiovascular events and mortality in a community cohort. Lipids Health Dis. 2025;24(1):137.","journal-title":"Lipids Health Dis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02831-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02831-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02831-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:00:02Z","timestamp":1757217602000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02831-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2831"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02831-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committees of University Hospital Morales Meseguer (reference: EST:20\/16) and University Hospital Virgen de la Arrixaca (reference: 2020-11-12-HCUVA) and was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its subsequent amendments. Written informed consent was obtained from all participants prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}